Literature DB >> 2368630

Sex steroid hormone receptors in normal and dysplastic bone disorders in children.

J M Pensler1, C B Langman, J A Radosevich, M L Maminta, M Mangkornkanok, R Higbee, A Molteni.   

Abstract

Children with monostotic and polyostotic bone dysplasias often exhibit localized bone overgrowth. We investigated the presence of nuclear estrogen and nuclear progesterone receptors by solid-phase radioimmunoassay, immunocytochemistry, and radioligand binding in osteoblast cell cultures derived from the areas of overgrowth of membranous bone, noninvolved membranous bone, and normal membranous bone from children undergoing elective craniotomy. Membranous bone of normal children had demonstrable levels of nuclear estrogen and progesterone receptors identified by radioimmunoassay and immunocytochemical assay. Two- to threefold increased levels of these receptors (p less than 0.001 versus normals) were found in cultures derived from the involved bone of two children with monostotic fibrous dysplasia and in one patient with polyostotic dysplasia (McCune-Albright syndrome). The noninvolved bone in our patients with fibrous dysplasia exhibited nuclear sex steroid hormone receptor levels similar to those in the normal children. Radioligand binding studies demonstrated increased sex steroid hormone receptors in cultures derived from involved osteoblasts. The presence of an increased level of sex steroid hormone receptor was accompanied by increased alkaline phosphatase activity and increased production of osteocalcin in vitro compared to normal or noninvolved bone. The mechanisms by which sex steroid hormone receptor levels are increased in the ostotic dysplasias remain to be established.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2368630     DOI: 10.1002/jbmr.5650050511

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  5 in total

1.  Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.

Authors:  H Michael; P L Härkönen; L Kangas; H K Väänänen; T A Hentunen
Journal:  Br J Pharmacol       Date:  2007-04-10       Impact factor: 8.739

2.  Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells.

Authors:  Y Mizuno; T Hosoi; S Inoue; A Ikegami; M Kaneki; Y Akedo; T Nakamura; Y Ouchi; C Chang; H Orimo
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

3.  Age-related changes in human oestrogen receptor alpha function and levels in osteoblasts.

Authors:  M A Ankrom; J A Patterson; P Y d'Avis; U K Vetter; M R Blackman; P D Sponseller; M Tayback; P G Robey; J R Shapiro; N S Fedarko
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

4.  Does the rate of orthodontic tooth movement change during the estrus cycle? A systematic review based on animal studies.

Authors:  Noura Saeed Sultan Almidfa; Athanasios E Athanasiou; Miltiadis A Makrygiannakis; Eleftherios G Kaklamanos
Journal:  BMC Oral Health       Date:  2021-10-14       Impact factor: 2.757

Review 5.  The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens.

Authors:  Edouard G Mills; Lisa Yang; Morten F Nielsen; Moustapha Kassem; Waljit S Dhillo; Alexander N Comninos
Journal:  Endocr Rev       Date:  2021-11-16       Impact factor: 19.871

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.